By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Takeda California 

Takeda San Diego
10410 Science Center Drive
San Diego  California  92121  U.S.A.
Phone: 858-622-8528 Fax: 858-550-0526


SEARCH JOBS


Industry
Biotechnology






Company News
Takeda Pharmaceuticals’s Investigational, Oral Proteasome Inhibitor Ixazomib Granted Breakthrough Therapy Designation By U.S. FDA For Relapsed Or Refractory Systemic Light-Chain Amyloidosis 12/1/2014 10:21:24 AM
Takeda Pharmaceuticals President Doug Cole Quits 11/21/2014 5:59:21 AM
Takeda Pharmaceuticals And Orexigen Therapeutics, Inc. (OREX) Announce Availability Of CONTRAVE® (naltrexone HCI And bupropion HCI) Extended-Release Tablets For Chronic Weight Management In Obese Adults 10/20/2014 8:22:26 AM
Takeda Pharmaceuticals And Lundbeck Inc. (LUN.CO) Announce Brintellix® (Vortioxetine) For The Treatment Of Major Depressive Disorder In Adults Is Now Available In Pharmacies 1/23/2014 10:46:15 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Deerfield Campus Among Chicago Tribune's 2013 Top 100 Workplaces 11/14/2013 12:04:45 PM
Takeda Pharmaceuticals, Arbor Pharmaceuticals Ink Licensing Agreement for EDARBI and EDARBYCLOR 9/13/2013 6:57:19 AM
Takeda Pharmaceuticals Presents New Long-Term Data on NESINA (alogliptin) in Combination With Metformin in Management of Type 2 Diabetes 6/24/2013 12:48:03 PM
Takeda California, Inc. and Sea Lane Biotechnologies, LLC Sign Licensing Agreement for Use of ConCIRT Libraries and Technology 6/12/2013 9:34:21 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) Gets $6.5 Million Diabetes-Drug Verdict Thrown Out 5/2/2013 8:13:39 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Actos Diabetes Drug Tied to Cancer, Jury is Told 4/16/2013 7:34:41 AM
12
//-->